Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis. | Nat Commun | 2023 | 37828014 | PubTator, text mining | PubMed |
| Uterine Leiomyoma in the Context of Uterine Didelphys: A Case Report. | Cureus | 2023 | 37809224 | PubTator, text mining | PubMed |
| Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide. | BMC Cancer | 2023 | 37803333 | PubTator, text mining | PubMed |
| Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy. | J Kidney Cancer VHL | 2023 | 37789902 | PubTator, text mining | PubMed |
| Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD-L1 expression. | Ibrain | 2023 | 37786553 | PubTator, text mining | PubMed |
| Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in a young patient presenting with a large uterus: A case report and review of the literature. | Case Rep Womens Health | 2023 | 37771423 | PubTator, text mining | PubMed |
| Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer. | Pharmaceutics | 2023 | 37765194 | PubTator, text mining | PubMed |
| Aspartic Acid in Health and Disease. | Nutrients | 2023 | 37764806 | PubTator, text mining | PubMed |
| Mixed Corticomedullary Tumor of the Adrenal Gland: A Case Report and Literature Review. | Medicina (Kaunas) | 2023 | 37763658 | PubTator, text mining | PubMed |
| A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer. | Int J Mol Sci | 2023 | 37762693 | PubTator, text mining | PubMed |
| A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma. | Diagnostics (Basel) | 2023 | 37761307 | PubTator, text mining | PubMed |
| A Neurosurgical Perspective on Brain Metastases from Renal Cell Carcinoma: Multi-Institutional, Retrospective Analysis. | Biomedicines | 2023 | 37760926 | PubTator, text mining | PubMed |
| An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases. | Curr Issues Mol Biol | 2023 | 37754269 | PubTator, text mining | PubMed |
| The Role of Morphology in Predicting Fumarate Hydratase-deficient Uterine Leiomyomas in Young Women. | Appl Immunohistochem Mol Morphol | 2023 | 37751278 | PubTator, text mining | PubMed |
| Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment. | Front Oncol | 2023 | 37746258 | PubTator, text mining | PubMed |
| Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases. | Cell Death Dis | 2023 | 37739961 | PubTator, text mining | PubMed |
| Cell-specific genome-scale metabolic modeling of SARS-CoV-2-infected lung to identify antiviral enzymes. | FEBS Open Bio | 2023 | 37734920 | PubTator, text mining | PubMed |
| Cardiac macrophages and emerging roles for their metabolism after myocardial infarction. | J Clin Invest | 2023 | 37712418 | PubTator, text mining | PubMed |
| Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism. | Br J Cancer | 2023 | 37689804 | PubTator, text mining | PubMed |
| Disruption of the Keap1-mTORC2 axis by cancer-derived Keap1/mLST8 mutations leads to oncogenic mTORC2-AKT activation. | Redox Biol | 2023 | 37688978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=14